Amna Nawaz
@PBSNewsHour·5.3M subscribers·62.2K videos
WATCH: Whistleblower says U.S. ‘should not proceed recklessly’ on potential virus treatments
Posted
May 14, 2020
Views
10,109
Likes
94
Engagement
0.93%
May 14, 2020
10,109
94
0.93%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
6:33Now PlayingRep. Buddy Carter, R-Ga., asked vaccine expert Rick Bright whether federal researchers could consider all possible treatments for the coronavirus, including hydroxychloroquine, the antimalarial drug promoted by President Donald Trump. “We should look at all options and make sure we evaluate their potential risk and safety and benefit of those within the context of a randomized, controlled, clinical study. In the context of an emergency, we should move swiftly and get that clinical data as urgently and quickly as possible. But we should not proceed recklessly without that clinical data,” Bright said. The former director of the Biomedical Advanced Research and Development Authority, Bright testified on Thursday before the House Committee on Energy and Commerce’s health subcommittee in a hearing dedicated to “protecting scientific integrity” of the country’s response to the coronavirus pandemic. In a whistleblower complaint filed last week, Bright said he was reassigned to a different position in late April for pushing back against the Trump administration’s virus response strategy.
Stream your PBS favorites with the PBS app
Find more from PBS NewsHour at
Subscribe to our YouTube channel
Snapchat: @pbsnews
Subscribe:
PBS NewsHour podcasts
Newsletters
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
